VSTM
Verastem, Inc.
NASDAQ · Healthcare · Biotechnology · US
$7.44
−1.46%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 4.59x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 13.48x
- Price / sales
- 7.70x
- Price / cash flow
- -4.15x
Enterprise value
- Enterprise value
- $621.8M
- EV / sales
- 7.10x
- EV / EBITDA
- -3.12x
- EV / EBIT
- -3.89x
- Market cap
- $673.8M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026